Glenmark Pharmaceuticals launches Rufinamide Tablets in US

Glenmark Pharmaceuticals said that it has launched Rufinamide Tablets USP, 200 mg and 400 mg in the US, which is a therapeutic equivalent of Banzel ... Read More